2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T4db8,

Summary Table

Feature	Detail
Risk Factors	Sexually active women of reproductive age (15-44), history of pelvic inflammatory disease (PID), multiple sexual partners, IUD insertion (within the first 3 weeks), prior tubo-ovarian abscess, instrumentation of the uterus
Etiology	Polymicrobial ascending infection from the lower genital tract; most commonly Neisseria gonorrhoeae and Chlamydia trachomatis as initiators, with secondary involvement of anaerobes (Bacteroides fragilis, Peptostreptococcus), facultative gram-negative rods (E. coli), and other vaginal flora
Patient Presentation	Acute lower abdominal/pelvic pain, high fever, vaginal discharge; often a woman with recent or undertreated PID who acutely worsens
Classic Physical Exam	Bilateral or unilateral adnexal tenderness with a palpable, fixed adnexal mass; cervical motion tenderness; guarding in the lower abdomen; toxic-appearing patient with high fever
Key Diagnostic Results	Transvaginal ultrasound showing a complex, thick-walled adnexal mass with internal echoes and septations; elevated WBC, ESR, CRP; blood cultures may be positive
Management	IV broad-spectrum antibiotics covering gram-negatives, gram-positives, and anaerobes; if no improvement in 48-72 hours, proceed to image-guided percutaneous drainage or surgical intervention
Keywords	"Adnexal mass with fever," "worsening PID," "complex adnexal mass on ultrasound," "failed outpatient PID treatment," "toxic-appearing young woman with pelvic pain"

1. Pathophysiology

Tubo-ovarian abscess represents the end-stage complication of untreated or inadequately treated pelvic inflammatory disease. The process begins with ascending infection from the cervix and endometrium, spreading through the fallopian tubes and eventually involving the ovary and surrounding pelvic structures.

The initial infection is typically triggered by sexually transmitted organisms, particularly N. gonorrhoeae and C. trachomatis. These pathogens damage the tubal epithelium and disrupt local immune defenses, creating an environment that allows secondary colonization by vaginal and enteric flora, including anaerobes like Bacteroides fragilis and facultative organisms like E. coli. This is why tubo-ovarian abscess is considered a polymicrobial infection, and antibiotic regimens must reflect this mixed flora rather than targeting a single organism.

As the infection progresses, the inflamed fallopian tube adheres to the ovary (often at or near a recent ovulation site, which provides an entry point into the ovarian parenchyma). The tube and ovary become a single, walled-off inflammatory mass filled with purulent material. This encapsulation is important to understand: the abscess wall creates a relative barrier to antibiotic penetration, which explains why many patients fail medical therapy alone and require drainage.

The reason patients present with severe systemic toxicity (high fever, tachycardia, leukocytosis) is that the abscess acts as a continuous source of bacteremia and cytokine release. When the abscess ruptures, massive peritoneal contamination occurs, leading to diffuse peritonitis and septic shock, which is the most feared and life-threatening complication.

2. Classification and Clinical Manifestation

Classification	Description	Clinical Features
Unruptured TOA	Intact abscess confined to the adnexa	Unilateral or bilateral pelvic pain, fever (often >38.3 C), adnexal mass on exam, cervical motion tenderness, purulent vaginal discharge; patient appears ill but hemodynamically stable
Ruptured TOA	Free spillage of purulent contents into the peritoneal cavity	Sudden worsening of pain, diffuse peritoneal signs (rigidity, rebound tenderness), septic shock (hypotension, tachycardia), signs of acute abdomen; this is a surgical emergency
Chronic/Recurrent TOA	Incompletely treated or recurrent abscess formation	Persistent low-grade pelvic pain, intermittent fevers, recurrent adnexal mass despite prior antibiotic courses; may present with tubal factor infertility or chronic pelvic pain

Unruptured TOA is the classic exam presentation: a young, sexually active woman with a history of PID or recent inadequate treatment who presents with worsening pelvic pain, high fever, and a palpable adnexal mass. The vignette will often describe a patient who was started on outpatient antibiotics for PID but returns days later with escalating symptoms.

Ruptured TOA is the scenario that tests your ability to recognize a surgical emergency. The key shift in the vignette is the sudden change from localized pelvic pain to diffuse abdominal pain with peritoneal signs and hemodynamic instability. This patient needs emergent laparotomy, not continued antibiotics.

3. Diagnostic Workup

Test	Role	Key Findings
Transvaginal ultrasound	Best initial test	Complex, multiloculated adnexal mass with thick walls, internal debris, echogenic fluid, and septations; loss of normal tubal and ovarian architecture
CT abdomen/pelvis with contrast	Used when ultrasound is equivocal or to evaluate for rupture and complications	Thick-walled, rim-enhancing fluid collection in the adnexa; useful for identifying free fluid suggesting rupture
MRI pelvis	Most accurate imaging modality	Superior soft tissue resolution; best for differentiating TOA from ovarian neoplasm or endometrioma when diagnosis remains unclear
CBC with differential	Supportive	Leukocytosis with left shift
ESR and CRP	Supportive, useful for monitoring treatment response	Elevated; CRP trends are helpful for assessing whether the patient is responding to antibiotics
Blood cultures	Supportive	May be positive, particularly with anaerobes or E. coli
Cervical cultures / NAAT	Identify initiating STI organisms	Positive for N. gonorrhoeae or C. trachomatis in many cases
Pregnancy test (beta-hCG)	Mandatory in all reproductive-age women with pelvic pain	Rules out ectopic pregnancy, which is the primary differential for adnexal mass with pain

Transvaginal ultrasound is the best initial test and the one you will be expected to order first. The classic finding is a complex adnexal mass with thick, irregular walls and internal echoes, often described as a "cog-wheel" pattern when the dilated tube is seen in cross-section. The presence of complete loss of plane between the tube and ovary (forming a single complex mass) is highly suggestive of TOA rather than simple pyosalpinx.

A pregnancy test must be obtained before any other workup in a reproductive-age woman with pelvic pain. This is a non-negotiable first step because ectopic pregnancy is a life-threatening condition that can mimic TOA, and the management is entirely different.

CT with contrast is used when the clinical picture is complicated, for example when you suspect rupture (free pelvic fluid, air within the abscess), or when the ultrasound is technically limited. MRI offers the best tissue characterization and is reserved for cases where the diagnosis remains uncertain after ultrasound, particularly when there is concern about an underlying ovarian malignancy.

Laparoscopy, while not routinely performed for diagnosis, can serve as both a diagnostic and therapeutic tool in ambiguous cases. It provides direct visualization of the pelvis and allows for drainage and culture collection.

4. Management and Treatment

Clinical Scenario	Management	Details
Unruptured TOA, initial therapy	IV broad-spectrum antibiotics	Multiple acceptable regimens (see below); admit to hospital for IV therapy and close monitoring
No clinical improvement at 48-72 hours	Image-guided percutaneous drainage	Transvaginal or transabdominal CT/ultrasound-guided drainage of the abscess; combined with continued IV antibiotics
Ruptured TOA	Emergency surgical intervention	Laparotomy (or laparoscopy in stable patients) for washout and drainage; concurrent IV antibiotics
Recurrent TOA or desire for definitive treatment	Surgical: unilateral salpingo-oophorectomy or total abdominal hysterectomy with bilateral salpingo-oophorectomy	Reserved for patients with completed childbearing, recurrent abscesses, or severe disease

Antibiotic Regimens

Regimen A (most frequently tested): Cefoxitin 2 g IV every 6 hours plus Doxycycline 100 mg IV or PO every 12 hours plus Metronidazole 500 mg IV every 8 hours. The addition of metronidazole to the standard PID regimen is the key distinction for TOA, because anaerobic coverage must be robust given the polymicrobial nature of the abscess.
Regimen B: Clindamycin 900 mg IV every 8 hours plus Gentamicin (loading dose 2 mg/kg IV, then 1.5 mg/kg IV every 8 hours or a single daily dose of 5 mg/kg). This combination provides broad gram-negative and anaerobic coverage. Clindamycin has the added benefit of good abscess wall penetration.
Regimen C (alternative): Ampicillin-sulbactam 3 g IV every 6 hours plus Doxycycline 100 mg IV or PO every 12 hours.

The patient should be monitored closely for clinical improvement within 48-72 hours. This is defined as defervescence, decreasing WBC, improving pain, and decreasing CRP. If there is no improvement, the next best step is image-guided percutaneous drainage, not switching antibiotics blindly. This is a high-yield management decision point on exams.

After clinical improvement on IV therapy, the patient is transitioned to oral antibiotics to complete a total of 14 days of therapy. A typical step-down regimen is Doxycycline 100 mg PO twice daily plus Metronidazole 500 mg PO twice daily.

Ruptured TOA changes the management entirely. A patient with signs of diffuse peritonitis and hemodynamic instability from a ruptured abscess requires emergent surgical intervention. This typically involves laparotomy with drainage, irrigation, and removal of necrotic tissue. Concurrent IV antibiotics are continued perioperatively.

All patients with TOA should be tested and treated for concurrent STIs, and partner notification and treatment should be initiated.

5. Differential Diagnosis and Distractors

Differential Diagnosis	Why It Is Similar	Key Discriminator
Ectopic pregnancy	Adnexal mass, lower abdominal pain, reproductive-age woman	Positive beta-hCG; absence of fever and leukocytosis; ultrasound shows an adnexal mass but without the thick-walled, complex, debris-filled appearance of TOA
Ovarian torsion	Acute onset unilateral pelvic pain, adnexal mass	Sudden onset, colicky pain with nausea/vomiting; absent Doppler flow to the ovary on ultrasound; typically afebrile with normal WBC
Appendicitis	Right lower quadrant pain, fever, leukocytosis	Pain begins periumbilically and migrates to McBurney point; no cervical motion tenderness or vaginal discharge; CT shows periappendiceal inflammation rather than adnexal mass
Endometrioma ("chocolate cyst")	Adnexal mass on ultrasound	Homogeneous "ground glass" echogenicity on ultrasound rather than the complex septated appearance of TOA; patient has cyclic pelvic pain and history of endometriosis; typically afebrile
Ovarian malignancy	Complex adnexal mass with solid and cystic components	Insidious onset without acute infection signs; ascites may be present; elevated CA-125; patient often older (postmenopausal); no fever or leukocytosis
Pelvic inflammatory disease (uncomplicated)	Bilateral lower abdominal pain, cervical motion tenderness, fever, vaginal discharge	No discrete adnexal mass on ultrasound; responds to outpatient oral antibiotics; exam reveals tenderness without a palpable mass

The most commonly tested differential is ectopic pregnancy versus TOA. Both present with adnexal pain and a mass in a reproductive-age woman. The pregnancy test is the single most important discriminating step. A positive beta-hCG redirects the entire workup toward ectopic pregnancy.

The distinction between uncomplicated PID and TOA is also heavily tested. The vignette will describe a patient with PID features, but the addition of a palpable adnexal mass or a complex mass on imaging is the trigger that upgrades the diagnosis to TOA and changes the management from outpatient oral antibiotics to inpatient IV therapy.

6. Traps and High-Yield Pearls

The most common way students lose points on TOA questions is by failing to upgrade the diagnosis from PID to TOA. The vignette will describe a textbook PID case, then bury the finding of an adnexal mass in the physical exam or ultrasound results. If you miss this, you will select outpatient PID management (oral ceftriaxone plus doxycycline) instead of the correct answer: hospital admission with IV antibiotics. Always scan for the words "adnexal mass," "complex mass," or "fullness in the adnexa" in any PID vignette.

The second major trap involves the 48-72 hour decision point. When a question describes a TOA patient already on appropriate IV antibiotics who is not improving after 48-72 hours, the next step is image-guided drainage, not changing the antibiotic regimen. Students who pick "switch to broader antibiotics" are falling into the distractor. The concept being tested is that an abscess with a thick wall cannot be sterilized by antibiotics alone once it reaches a certain size (generally >7-8 cm).

The third pearl is the ruptured TOA recognition. If the vignette describes acute deterioration with sudden diffuse abdominal pain, peritoneal signs, and hemodynamic instability, this is a ruptured abscess and a surgical emergency. The correct answer is laparotomy, not continued antibiotics and not percutaneous drainage.

Finally, never forget the mandatory pregnancy test. Regardless of how classic the presentation for TOA appears, the correct first step in any reproductive-age woman with pelvic pain and an adnexal mass is a beta-hCG. The exam will test whether you reflexively rule out ectopic pregnancy before committing to the TOA workup.

1e:["$","$L2d",null,{"article":{"id":"c3360ae5-a44c-4048-abb4-c8cce42f6259","title":"Abses Tubo-ovarium","content":"$2e","category":"Reproduksi","created_at":"2026-05-16T18:25:42.409342+00:00","status":"published","subcategory":null},"questionCount":0,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]